Insider Transactions in Q1 2025 at Aziyo Biologics, Inc. (AZYO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
12,413
-1.76%
|
$24,826
$2.89 P/Share
|
|
Mar 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,000
+7.57%
|
-
|
|
Mar 10
2025
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,706
-3.57%
|
$32,118
$3.0 P/Share
|
|
Mar 10
2025
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,083
+8.28%
|
-
|
|
Mar 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,613
-5.7%
|
$13,839
$3.0 P/Share
|
|
Mar 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+13.38%
|
-
|
|
Mar 08
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,287
+0.4%
|
-
|
|
Feb 03
2025
|
High Cape Capital, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
840,000
+4.23%
|
$1,680,000
$2.5 P/Share
|